Offerings // Amneal Pharmaceuticals, Inc.

AMRX offering history

Every offering-related filing in Amneal Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 695 filings back to Nov 21, 2017.

Last executed offering

Aug 10, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Sep 3, 2026

S-3ASR — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Sep 3, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Aug 10, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 22, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 14, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 14, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 24, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 24, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 2, 2022	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Mar 2, 2022	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Mar 1, 2019	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Nov 13, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 7, 2018	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Aug 13, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 12, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 7, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 11, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 10, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 9, 2018	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
May 9, 2018	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 7, 2018	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 7, 2018	RW →	WITHDRAWN	Registration withdrawn
May 7, 2018	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Apr 13, 2018	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Mar 7, 2018	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Feb 12, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 9, 2018	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin

AMRX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full AMRX workspace →

AMRX offering FAQ

When did AMRX last execute an offering?

Per SEC filings, Amneal Pharmaceuticals, Inc.'s most recent priced offering document is a 8-K filed 2026-08-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did AMRX last announce or register an offering?

The most recent registration is a S-3ASR filed 2026-09-03. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.